Lenalidomide - PDFSEARCH.IO - Document Search Engine

Lenalidomide
Results: 231

#	Item
161	REVLIMID ® (lenalidomide) Patient Prescription Form Today’s Date Date Rx Needed Patient Last Name Add to Reading List Source URL: www.revlimidrems.com Language: English - Date: 2014-02-13 10:20:58 Pharmacology Clinical pharmacology Medical prescription Patient safety Lenalidomide Celgene Pharmacy Medicine Pharmaceutical sciences Immunosuppressants
162	Prescriber Guide to REMS ™ Risk Evaluation and Mitigation Strategy (REMS)™ Program Due to its structural similarity to thalidomide, a known teratogen, Add to Reading List Source URL: www.revlimidrems.com Language: English - Date: 2014-02-13 10:20:58 Medical terms Immunosuppressants Patient safety Lenalidomide Celgene Pharmacy Thalidomide Medical prescription Myelodysplastic syndrome Medicine Health Pharmacology
163	Pharmacy Guide to REMS ™ Risk Evaluation and Mitigation Strategy (REMS)™ Program Important information about REVLIMID® (lenalidomide) Add to Reading List Source URL: www.revlimidrems.com Language: English - Date: 2014-04-11 12:58:26 Pharmacology Medical terms Immunosuppressants Pharmacy Lenalidomide Celgene Medical prescription Pharmacist Patient safety Medicine Health Pharmaceutical sciences
164	Pharmaceutical Management Branch Cancer Therapy Evaluation Program Division of Cancer Treatment and Diagnosis National Cancer Institute 6130 Executive Blvd * Suite 7149 Rockville, Maryland 20852 Add to Reading List Source URL: ctep.cancer.gov Language: English - Date: 2011-02-16 03:52:05 Cancer treatments Pharmacology Oncology Drug discovery Lenalidomide Thalidomide Sirolimus Chemotherapy Combined oral contraceptive pill Medicine Immunosuppressants Health
165	Microsoft Word - 2014_02_04_3rd_Amended_Complaint_Filed Add to Reading List Source URL: freepdfhosting.com Language: English - Date: 2014-02-06 11:13:57 Immunosuppressants Carcinogens Leprosy Phthalimides Thalidomide Celgene Lenalidomide Food and Drug Administration Off-label use Medicine Pharmacology Pharmaceutical sciences
166	Patient Guide to REMS ™ Risk Evaluation and Mitigation Strategy (REMS)™ Program This guide provides you important Add to Reading List Source URL: www.revlimidrems.com Language: English - Date: 2014-02-13 10:20:58 Fertility Lenalidomide Celgene Thalidomide Condom Pregnancy Emergency contraception Sexual intercourse Birth control Medicine Immunosuppressants Medical technology
167	REMS ™ Education and Counseling Checklist for Pharmacies REVLIMID Risk Evaluation and Mitigation Strategy (REMS)™ program (formerly known as the RevAssist® program) Add to Reading List Source URL: www.revlimidrems.com Language: English - Date: 2014-05-01 17:35:44 Lenalidomide Celgene Pharmacology Pulmonary embolism Medical prescription Combined oral contraceptive pill Rad Deep vein thrombosis Medicine Health Immunosuppressants
168	MEDICATION GUIDE REVLIMID® (rev-li-mid) (lenalidomide) capsules What is the most important information I should know about REVLIMID?  Add to Reading List Source URL: www.revlimidrems.com Language: English - Date: 2014-04-29 14:56:06 Lenalidomide Celgene Thalidomide Pregnancy Myelodysplastic syndrome B-cell chronic lymphocytic leukemia Cancer Medicine Health Immunosuppressants
169	REMS ™ Prescriber Enrollment Form All prescribers must be certified to prescribe REVLIMID® (lenalidomide). To become certified the prescriber must: 1. Complete the Prescriber Enrollment Form, which is required for R Add to Reading List Source URL: www.revlimidrems.com Language: English - Date: 2014-04-11 12:58:40 Immunosuppressants Pharmacology Lenalidomide Celgene Medical prescription Pharmacy Methadone Emergency contraception Chemistry Medicine Organic chemistry
170	Annual Report[removed]Multiple Myeloma Research Foundation Mission Statement Add to Reading List Source URL: www.themmrf.org Language: English - Date: 2009-08-30 17:10:01 Cancer organizations Norwalk Connecticut Immunosuppressants Multiple Myeloma Research Foundation Multiple Myeloma Research Consortium Kathy Giusti Lenalidomide Bortezomib Thalidomide Medicine Oncology Cancer research

UPDATE